These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 3873102)
1. Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Fuller RW; Hemrick-Luecke SK Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):17-25. PubMed ID: 3873102 [TBL] [Abstract][Full Text] [Related]
2. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP. Fuller RW; Hemrick-Luecke SK Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):167-72. PubMed ID: 3764080 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Fuller RW; Hemrick-Luecke SK J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853 [TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice. D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368 [TBL] [Abstract][Full Text] [Related]
5. Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors. Fuller RW; Hemrick-Luecke SK; Robertson DW Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):57-65. PubMed ID: 2417293 [TBL] [Abstract][Full Text] [Related]
6. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice. Leng A; Mura A; Hengerer B; Feldon J; Ferger B Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025 [TBL] [Abstract][Full Text] [Related]
7. 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Finnegan KT; Irwin I; Delanney LE; Ricaurte GA; Langston JW J Pharmacol Exp Ther; 1987 Sep; 242(3):1144-51. PubMed ID: 3498815 [TBL] [Abstract][Full Text] [Related]
8. Cocaine blocks the dopamine depletion induced by MPTP. Mayer RA; Jarvis MF; Wagner GC Res Commun Chem Pathol Pharmacol; 1985 Jul; 49(1):145-8. PubMed ID: 3875884 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heart. Fuller RW; Hemrick-Luecke SK; Robertson DW Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):129-32. PubMed ID: 3258433 [TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274 [TBL] [Abstract][Full Text] [Related]
11. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum. Chan P; Langston JW; Di Monte DA J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain. Fuller RW; Robertson DW; Hemrick-Luecke SK J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775 [TBL] [Abstract][Full Text] [Related]
13. The neurochemical and clinical effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in small animals. Donnan GA; Kaczmarczyk SJ; Solopotias T; Rowe P; Kalnins RM; Vajda FJ; Mendelsohn FA Clin Exp Neurol; 1986; 22():155-64. PubMed ID: 3495376 [TBL] [Abstract][Full Text] [Related]
14. Depletion of heart norepinephrine in mice by some analogs of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). Fuller RW; Hemrick-Luecke SK Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):147-56. PubMed ID: 3496637 [TBL] [Abstract][Full Text] [Related]
15. Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Chiba K; Kubota E; Miyakawa T; Kato Y; Ishizaki T J Pharmacol Exp Ther; 1988 Sep; 246(3):1108-15. PubMed ID: 3262153 [TBL] [Abstract][Full Text] [Related]
16. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Holmer HK; Keyghobadi M; Moore C; Meshul CK Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice. Fuller RW; Hemrick-Luecke SK Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):687-90. PubMed ID: 3878976 [TBL] [Abstract][Full Text] [Related]
18. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid. Steranka LR Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818 [TBL] [Abstract][Full Text] [Related]
19. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507 [TBL] [Abstract][Full Text] [Related]
20. Selective alterations of gene expression in mice induced by MPTP. Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]